LGALS3 and Miyoshi myopathy: In summary, we have identified a key immunosuppressive role for LAG3 and its ligand GAL-3 in regulating innate and adaptive immunity in MM and provide the rationale for targeting LAG3/GAL-3, alone and in combination immunotherapeutic approaches, to improve patient outcome in MM.